Sponsor:
AstraZeneca
Code:
NCT05417594
Conditions
Advanced Solid Malignancies
Eligibility Criteria
Sex: All
Age: 18 - 70+
Healthy Volunteers: Not accepted
Interventions
AZD9574
Temozolomide
[11C]AZ1419 3391
Datopotamab Deruxtecan (Dato-DXd)
Trastuzumab Deruxtecan (T-DXd)
Study Details
Eligibility Criteria
Study Design
Interventions and Outcome Measures
Central Contacts and Locations